| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:59400064:1874 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:59400064:1874?format=raw |
LEADER: 01874mam a2200397 a 4500
001 4052343
005 20221027024843.0
008 960702t19961996enka 001 0 eng d
010 $agb 96053733
015 $aGB96-53733
020 $a3527294155 :$c£54.00
035 $a(OCoLC)35137254
035 $a(OCoLC)ocm35137254
035 $9ALT4497HS
035 $a(NNC)4052343
035 $a4052343
040 $aUKM$cUKM$dNNC-M$dOrLoB-B
082 04 $a615.1072$220
100 1 $aSedlacek, H. H.$0http://id.loc.gov/authorities/names/n88051550
245 10 $aWays to successful strategies in drug research and development /$cH. Harald Sedlacek, Alice M. Sapienza, Volker Eid.
260 $aWeinheim ;$aCambridge :$bVCH,$c[1996], ©1996.
300 $axiii, 265 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aBibliography: p. 241-251.
500 $aIncludes index.
505 00 $gI.$tIntroduction --$gII.$tThe ethical background --$gIII.$tThe research and development project --$gIV.$tMeasures to reduce risks --$gV.$tProject management --$gVI.$tCorporate and technology strategy --$gVII.$tLeadership and management --$gVIII.$tManaging for innovation --$gIX.$tThe social and political bearings on innovation --$gX.$tEthical obligations.
650 0 $aDrugs$xResearch$xMethodology.
650 2 $aPharmacology.$0https://id.nlm.nih.gov/mesh/D010600
650 2 $aResearch Design.$0https://id.nlm.nih.gov/mesh/D012107
650 2 $aDrug Evaluation, Preclinical.$0https://id.nlm.nih.gov/mesh/D004353
650 2 $aDrug Evaluation.$0https://id.nlm.nih.gov/mesh/D004341
653 0 $aDrugs$aMarket research
700 1 $aSapienza, Alice M.$0http://id.loc.gov/authorities/names/n85822408
700 1 $aEid, Volker.$0http://id.loc.gov/authorities/names/n83059739
852 00 $boff,hsl$hRM301.25$i.S42 1996